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In vivo detection of acute rat renal allograft rejection by MRI threatened by acute and chronic rejection, as well as
with USPIO particles. by complications such as infection and nephrotoxicity
Background. Magnetic resonance imaging (MRI) for non- caused by immunosuppression [1–3]. Thus, a proper evalu-invasively detecting renal rejection was developed by monitoring
ation of the progression of graft rejection could have athe accumulation of macrophages labeled with dextran-coated
significant impact on the management and outcome ofultrasmall superparamagnetic iron oxide (USPIO) particles at
the rat renal allografts during acute rejection. transplantation patients. Although numerous techniques
Methods. Five groups of male rats with DA→BN renal allo- have been used for the detection of renal allograft rejec-
grafts and one group with BN→BN renal isografts were investi- tion, development of specific, sensitive, and non-invasivegated by MRI before, immediately after, and 24 hr after intra-
methods for the diagnosis of rejection is still a majorvenous infusion with different doses of USPIO particles. All
challenge in the field of renal transplantation. Renalinfusions were done on post-operative day 4. MRI experiments
were carried out in a 4.7-Tesla instrument using a gradient echo biopsy is generally accepted as the “gold standard” for
sequence. diagnosing graft rejection. However, this procedure is
Results. MR signal intensity (MRSI) of the cortex was found not only prone to sampling errors, but it also exposesto decrease with higher dosages of USPIO particles. In the
patients to the risks of possible bleeding, kidney rupture,absence of USPIO infusion, a decrease in MRSI was seen in
infection, and arterial venous fistula [3, 4].the medulla region, presumably due to hemorrhage associated
with renal graft rejection, while no significant change was ob- Magnetic resonance imaging (MRI) is an established
served in the cortex. The optimal dose of USPIO particles for methodology for both clinical applications and research
visualizing rejection-associated changes in our rat kidney model in biomedical sciences. Its sensitivity, non-invasiveness,appears to be 6 mg Fe/kg body weight. Iron staining results
and versatility allow a comprehensive characterizationcorrelated with the MRSI data, indicating that the signal reduction
of a disease state. An aspect of particular relevance inin the MR images was due to the presence of iron. Immunohisto-
chemical results indicated that USPIO particles were mostly the application to transplanted organs is that MRI can be
taken up by infiltrating macrophages in the rejecting grafts. used to detect organ rejection non-invasively, allowing a
Conclusions. Our results suggest that MRI with intravenous sequential monitoring of the progression of graft statusadministration of dextran-coated USPIO particles appears to
and its responses to immunosuppression [5]. MR signalbe a valuable and promising tool that can be used as a non-
intensity (MRSI) is governed by a number of parametersinvasive and sensitive method to detect graft rejection in renal
transplantation. [proton density, relaxation times (T1, T2, T2*), water dif-
fusion, and water exchange rates, etc.] that depend on
the physical and physiological properties of the tissue.
Renal transplantation is a commonly accepted thera- Dextran-coated superparamagnetic iron oxide (US-
peutic modality for treatment of patients with end-stage PIO) particles are excellent MR contrast agents due to
renal disease. However, long-term graft survival is still their large magnetic susceptibility produced by iron [6].
Since USPIO particles have an intravascular distribution,
a relatively long half life of about two hours in rat blood,
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and are taken up by macrophages in widespread areasiron oxide particles, macrophages, rat renal transplantation, diagnosis
of renal graft rejection. [7, 8], they have been used as a tissue MRI contrast agent
[9–13]. In the kidney, USPIO particles also have beenReceived for publication June 14, 2001
used as vascular contrast agents for assessing perfusionand in revised form August 29, 2001
Accepted for publication October 1, 2001 rates [14, 15] and as a probe for detecting intrarenal
macrophage infiltration [16, 17]. 2002 by the International Society of Nephrology
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Table 1. Experimental design for this study
POD 4, 2nd MRI
Day 0 POD 4, 1st MRI Infuse USPIO 5 min after POD 5, 3rd MRI
Groups KTx D→R 10 min before USPIO infusion mg Fe/kg USPIO infusion 24 hrs after USPIO infusion
I (N  8) DA→BN allograft Three were sacrificed for histology 0 Sacificed for histology,
immunohistochemistry
II (N  5) DA→BN allograft 1 Sacrificed for histology,
immunohistochemistry
III (N  6) DA→BN allograft 3 Sacrificed for histology,
immunohistochemistry
IV (N  7) DA→BN allograft 6 Sacrificed for histology,
immunohistochemistry
V (N  6) DA→BN allograft 12 Sacrificed for histology,
immunohistochemistry
VI (N  8) BN→BN isograft Three were sacrificed for histology 6 Sacificed for histology,
immunohistochemistry
Abbreviations are: KTx, kidney transplantation; D, donor; R, recipient; DA, inbred DA rat strain (RT1a); BN, Brown Norway rat strain (RT1n); POD, post-
operative day; MRI, magnetic resonance imaging; USPIO, dextran-coated superparamagnetic iron oxide.
Renal graft rejection is characterized histologically by (NIH publication No. 96-03, revised 1996). Animal pro-
tocols were approved by the Institutional Animal Carethe infiltration of predominantly T cells and macrophages
at the rejection site. Although T-cell infiltration is a hall- and Use Committee of Carnegie Mellon University. The
present study was performed on six groups of ratsmark of renal allograft rejection, early and persistent
macrophage infiltration is strongly associated with the (groups I to VI, Table 1). Eight BN rats that received
BN kidneys served as an isograft group (group VI). Thepresence of allograft rejection [18–22]. Thus, it is of inter-
est to develop non-invasive methods using MRI to detect other 32 BN rats received renal allografts from DA rats
and were used as the acute rejection group. Three eachthe accumulation of these cells labeled with USPIO par-
ticles. A number of studies have shown that sufficient from both isograft and allograft recipients were sacrificed
on post-operative day (POD) 4 to characterize the patho-amounts of dextran-coated USPIO particles can be in-
corporated into cells so that the labeled cells can be logical condition of the grafts before USPIO infusion.
The remaining allograft recipients were divided into fivedetected by MRI [11, 23–25]. Our preliminary results
have shown that dextran-coated USPIO particles can groups (groups I to V, N  5 to 7/group) that were
studied by MRI 10 minutes before, 5 minutes after, andbe used to detect renal graft rejection by monitoring
macrophage infiltration by MRSI reduction [17], but the 24 hours after infusion with 0 [phosphate-buffered saline
(PBS) only], 1, 3, 6, or 12 mg Fe/kg body weight ofoptimal conditions as well as the cause of MRSI reduc-
tion of the renal grafts remain to be determined. dextran-coated USPIO particles (or 0, 18, 54, 108 or 216
mol Fe/kg), respectively. The remaining five isograftIn the present study, we have extended and refined our
earlier work to detect the accumulation of macrophages recipients underwent the same study with infusion of 6
mg Fe/kg. All USPIO infusions were done on POD 4.labeled with dextran-coated USPIO particles at the re-
jecting rat renal graft as a means to detect kidney rejec-
Renal transplantationtion. Our results are very promising, suggesting that our
MRI approach may offer a new non-invasive method to Renal transplantation was performed according to
detect rejection in renal transplantation. Lee’s microsurgical technique [26] with minor modifica-
tions. In brief, after nephrectomy on the left side of the
recipient, the graft renal artery and vein were anasto-
METHODS mosed end-to-side with the recipient abdominal aorta
Animals and experimental design and inferior vena cava, and an end-to-end anastomosis
of the ureter was carried out with four single stitchesInbred male DA (RT1a) and Brown Norway (BN,
using 10-0 suture (Sherwood Medical, St. Louis, MO,RT1n) rats were purchased from Harlan-Sprague Daw-
USA). The total ischemic time for the graft was aboutley, Inc. (Indianapolis, IN, USA) at 8 to 10 weeks of age
25 minutes. The recipient right kidney was kept intactand housed in the animal facility of the Pittsburgh NMR
as an internal control for MRI measurements.Center for Biomedical Research on a diet of standard
rat chow and water ad libitum. Animals received care
USPIO particlesin compliance with the Principles of Laboratory Animal
Care and the Guide for Care and Use of Laboratory Ani- Dextran-coated USPIO particles were synthesized in
our laboratory according to the method of Palmacci andmals, published by the National Institutes of Health
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Fig. 1. Regions of interest (ROIs) for mea-
surements of magnetic resonance (MR) signal
intensity. ROIs for cortex and medulla of kid-
neys were traced by hand on the center slice
of each MRI tested kidney. These ROIs were
used to analyze the before- and after-infusion
images from all groups of this study.
Josephson [27] with slight modifications [25]. Quantita- shielded gradient insert. Coronal MR images of bilateral
kidneys were obtained using a 7-cm diameter Brukertive determination of iron in the particle suspension was
performed for all samples using a spectrophotometric RF coil at 10 minutes before, 5 minutes after, and 24
hours after infusion of USPIO particles. The imagingmethod [28]. Iron-core size measured with transmission
electron microscopy (TEM) was found to be in the range sequence consisted of a gradient echo sequence with
TR/TE  300/7 ms; flip angle  Ernst angle; FOV  74.0 to 7.5 nm. The mean diameter of whole particles
measured by laser light scattering was 27  1.1 nm. The cm; matrix size  256  256; 8 contiguous slices with
thickness of 1 mm, three averages; scan time  3.8 min.MR relaxivities, R1 (spin-lattice relaxation rate constant,
1/T1, per mole of Fe in USPIO) and R2 (spin-spin relax- The average changes of MRSI were measured in two
different compartments, that is, cortex and medulla ination rate constant, 1/T2, per mole of Fe in USPIO),
measured at 0.47 Tesla (20 MHz) using a Bruker Mini- each transplanted kidney. Regions of interest (ROIs) for
cortex and medulla were traced manually on the centerspec (Bruker Canada, Ltd., Melton, Ont., Canada) at
27.8C were 3.83  104 and 10.8  104 mol Fe1s1, slice of each kidney (Fig. 1). These ROIs were used to
analyze MR images before and after infusion of USPIOrespectively. Prior to infusion, a portion of the stock
suspension of USPIO particles was dialyzed against PBS, particles. MRSI was normalized to that of the psoas
major muscle of the same rat. The MRSI reduction infilter sterilized, and assayed for iron content [28]. The
USPIO suspensions were diluted with PBS such that a each animal was calculated according to (SI1 SI2)/ SI1
100%, where SI1 and SI2 were the signal intensities beforetotal volume of 1 mL injected intravenously over about
two seconds for each individual animal gave the required and after USPIO infusion, with both first normalized to
the MRSI of the muscle.mg Fe/kg body weight.
In vivo MRI experiments and MR signal Histological, iron staining, and
immunohistochemical analysesintensity measurement
A 30-cm PE50 extension tube was inserted into the In addition to the six recipients that were sacrificed
on POD 4, native and graft kidneys of all recipient ratsright jugular vein of the recipient for infusing USPIO
particles or PBS before MRI. During the MRI experi- were harvested immediately after the last MRI measure-
ment on POD 5. The kidneys were fixed in 3.7% para-ments, all of the rats were under general anesthesia with
2% isoflurane in a nitrous oxide/oxygen (2:1) mixture formaldehyde, embedded in paraffin, and then cut longi-
tudinally into sections of 5-m thickness with the sameusing endotracheal intubation and placed in the supine
position in the center of the coil. MRI measurements coronal orientation as the orientation of the MRI section.
In order to correlate the iron distribution with monocyte/were performed on a Bruker AVANCE DRX MR in-
strument operating at 4.7 Tesla equipped with a 40-cm macrophage or T-cell locations, serial sections from each
sample were stained with hematoxylin and eosin (H&E),horizontal bore superconducting solenoid and a 15-cm
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Fig. 4. Perl’s Prussian blue staining at post-
operative day (POD) 5, 24 hours after infu-
sion, shows the visible distribution of the iron
particles. A, B, C, D, E, and F show represen-
tative staining of the cortex from groups I, II,
III, IV, V, and VI, respectively. Comparing B
and C with D and E, there are many more
visible iron particles in the latter as indicated
by arrows. Almost no visible iron plaques were
observed in the isograft (F). Original magnifica-
tion, 200. Details are in the text and Table 1.
Fig. 8. Correlation between iron staining and
ED1cell staining in an allograft. Representa-
tive staining of the cortex of a POD 5 allograft
from group IV is shown. (A) Iron staining and
(B) ED1 cells (monocytes/macrophages). The
distribution of the iron-containing cells corre-
lates well with the presence of ED1 cells as
indicated by arrows. Original magnification,
400. Detailed experimental conditions are
in the text and Table 1.
Perl’s Prussian blue (iron staining), anti-rat macrophage
lineage monoclonal antibodies (ED1; Serotec, Raleigh,
NC, USA), and anti-rat T-cell monoclonal antibodies
(CD3; DAKO, Carpinteria, CA, USA). All stainings
were performed in the Transplantation Pathology Labo-
ratory of the University of Pittsburgh Medical Center in
a blind manner. The numbers of ED1 or CD3 cells that
infiltrated the renal cortex and medulla were counted in
a blinded manner as the number of cells per field of view
(c/FV) at a magnification of 400, with five randomly
chosen fields/section/rat. Perl’s Prussian blue staining for
iron was analyzed automatically by summing the lumi-Fig. 2. Analysis of the Perl’s Prussian blue iron staining. (A) An exam-
nance of the blue regions in the image of slices stainedple of the original RGB images of the renal graft. (B) The extraction
of the Perl’s Prussian blue color of the iron stains from the example in for iron. The details are described below. Three fields
panel A. A comparison of the two figures shows that the algorithm
of view were evaluated in a blind manner for each sectionextracts the blue color of the iron quite accurately. Details are in the
text. at a magnification of 200.
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Analysis of Perl’s Prussian blue iron staining Statistical analysis
Data from this study were expressed as mean SD. Dif-In the renal graft images, the iron stain, which indicates
ferences between groups were identified using ANOVAthe presence of the USPIO particles, appeared blue in
with the Bonferroni multiple comparisons post-test.contrast to the background that was purple to magenta.
P values less than 0.05 were considered significant.These images were collected in the RGB (red-green-
blue) format. To analyze the Perl’s Prussian blue iron
staining, we started by transforming each of the RGB RESULTS
images into the HSV (hue-saturation-value) coordinate
In vivo MRI experiments on renal graftssystem. The HSV color space was chosen over the RGB
Recipients from six groups of rats (Table 1) were ex-format because the RGB format, though commonly used
amined by MRI 10 minutes before, 5 minutes after, andfor display, was not perceptually uniform. In the HSV
24 hours after intravenous infusion with 0 (PBS only),format, hue describes the specification of the basic color
1, 3, 6, or 12 mg Fe/kg body weight of dextran-coatedin terms of its angular position on the “color wheel.” As
USPIO particles. Representative MR images of rat kid-hue varies from 0 to 1.0 (or 360), the corresponding
ney grafts from this study are shown in Figure 3. In thecolor changes from red to yellow, green, cyan, blue, ma-
absence of USPIO infusion (that is, infused with PBS),genta and back to red again. Saturation indicates the
a decrease in MRSI was seen in the allograft medullapurity of the color. A color appears dull (or gray) at low
regions, presumably due to hemorrhage associated withsaturation, and it becomes increasingly vivid at higher
renal graft rejection, while no significant change wassaturation levels. The last component of the HSV color
observed in the cortex (Fig. 3C). We have probed thespace is the value, often also referred to as the brightness,
MRSI changes in the cortex using a dose-dependent re-which represents the degree of intensity of the light.
sponse to the USPIO particles on POD 5. MRSI de-After transforming the RGB image into the HSV color
creases with dosages of USPIO particles from 0 to 12space, the blue color was then extracted in the image by
mg Fe/kg of body weight (Table 2; Figures 3C, F, I, L,thresholding. A certain range of the hue components of
and O). The MRSI in the allograft medulla regions shows
the HSV image was chosen. Although the typical hue
no clear difference among the five groups after infusion
range for the blue color was between 0.6 and 0.75, in
of various doses of USPIO particles on POD 5. Based
our algorithm these thresholds were adjustable by the on these results, 6 mg Fe/kg appears to be the optimal dos-
expert user, since different image slides had varying age for the visualization of rejection-associated changes
brightness intensity and the choice of blue in each of the in the renal cortex. Figure 3L shows MR images of an
slides was subjective. In some of these slides where the allograft at 24 hours after infusion of 6 mg Fe/kg of
brightness intensity was low, the expert user was some- USPIO particles, and Figure 3R shows images of an
times not able to differentiate the dark blue pixels from isograft under the same conditions. While a significant
the dark purple ones. This problem was resolved by a darkening is seen in the allografts, no significant change
non-linear filter operation: median filtering. This median in MRSI is observed in the isografts.
filtering filtered out possible false dark purple pixels: a
5 by 5 window was sliced through each of the blue pixel Iron staining of renal grafts
candidates obtained from the previous step; this pixel Representative images of Perl’s Prussian blue staining
was kept if there were more blue pixels than purple of the cortex from kidney grafts of this study are shown
pixels in the 5 by 5 window. in Figure 4. Iron staining in the cortex of allografts after
Finally, for display purposes, these true blue pixels infusion of 6 or 12 mg Fe/kg of USPIO particles (Figs.
were transformed back into the RGB space, and all the 4D and E) shows much more dense and more widespread
luminance values of all the true blue pixels were summed. staining than is exhibited in lower dosages of USPIO
The luminance value (Y) is given by [29] (Figs. 4B and C). There is no visible iron staining in the
cortex of the allografts from group I (Fig. 4A), that is,Y  0.177 R  0.813 G  0.011 B (Eq. 1)
infused with PBS only. Iron staining in the medulla does
where R, G, and B are the intensities of the red, green, not show much difference among five allograft groups
and blue components of the image, respectively. Figure (results not shown) after infusion of various doses of
2A depicts an example of the original RGB images of USPIO particles; the darkening of the medulla in the
the renal graft with 12 mg Fe/kg USPIO infusion. Figure MR imaging is believed to be due to hemorrhage. There
2B shows the extraction of the Perl’s Prussian blue color are no visible iron particles in the cortex of the isografts
of the iron stains from Figure 2A. This figure clearly (Fig. 4F) at 24 hours after infusion of 6 mg Fe/kg of
indicates that the algorithm extracts the blue color of USPIO particles.
Table 2 summarizes the results of MRSI reductionthe iron quite accurately.
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Fig. 3. Representative gradient-echo MR im-
ages showing the effect of different doses of
dextran-coated ultrasmall superparamagnetic
iron oxide (USPIO) particle infusion. The trans-
planted kidneys appear on the right (arrow)
and the native kidneys appear on the left in
these panels. The images from immediately
before, 5 minutes after, and 24 hours after
infusion of USPIO particles are shown in the
first, second, and third columns, respectively.
Allograft images A, B, and C are from group
I without USPIO infusion (infused with PBS
only); D, E, and F are from group II with 1
mg Fe/kg; G, H, and I are from group III with
3 mg Fe/kg; J, K, and L are from group IV
that with 6 mg Fe/kg; and M, N, and O are
from group V with 12 mg Fe/kg. P, Q, and R
show isograft images from group VI with 6
mg Fe/kg. MR images of the coronal view of
the grafts are shown in each case. For details,
see the text and Table1.
and intensity of iron staining of cortex at 24 hr after shows a significant difference between allografts and iso-
grafts 24 hours after an infusion of 6 mg Fe/kg of USPIOinfusion of different dosages of dextran-coated USPIO
particles. Analyses show a statistically significant MRSI particles (P  0.0001). MRSI reduction appears to level
off above 6 mg Fe/kg, and this dosage of USPIO appearsreduction in the cortex of renal allografts at POD 5, 24
hours after an infusion of 6 or 12 mg Fe/kg of USPIO to be an optimal one for the chosen MRI pulse sequence.
In a separate experiment to determine the dynamic be-particles compared to rats infused with 0, 1 or 3 mg Fe/kg
(P  0.001). MRSI changes in the medulla of allografts havior of MRSI after a bolus USPIO infusion, we have
also found that a dose of 6 mg Fe/kg gives a reproducibleshow no statistical difference among the five groups after
infusion of various doses of USPIO particles (P 	 0.23). wash-in/wash-out curve [30].
Our iron staining analysis indicates that there is someHowever, MRSI in the cortex and medulla of renal grafts
Table 2. MR signal intensity reduction and iron staining of kidney grafts 24 hours after infusion of USPIO particles on POD 5
MRSIa reduction % Iron stainingb arbitrary units
USPIO
Group N mg Fe/kg Cortex Medulla Cortex Medulla
I 5 0 47.567.05 79.563.81 1.080.67 NAg
II 5 1 52.725.83 78.303.68 18.144.96 NAg
III 6 3 68.034.48 81.115.39 303.6750.40c NAg
IV 7 6 84.541.91c,d 84.403.16 951.8578.06c,d NAg
V 6 12 86.994.19c,d 86.014.41 1297.35288.56c,d NAg
VI 5 6 16.009.20e 9.705.50e 29.6118.95f 10.245.45
a The MRSI values from all groups in this study are represented as meanSD
b The iron staining values from all groups in this study are presented as meanSD
c P  0.0001 vs. Groups I and II
d P  0.001 vs. Group III
e P  0.0001 vs. Groups I, II, III, and IV
f P  0.0001 vs. Groups III, IV, and V
g NA, no data analysis available; due to hemorrhage in the medulla, there is no visible difference in the iron staining of the medulla among the five allograft groups
USPIO particles. There is a good correlation between
these two sets of data.
Histological analyses of the renal grafts
Hematoxylin and eosin staining of renal grafts shows
that the morphological alteration appears as acute rejec-
tion Grade II [31] in all three allografts harvested on
POD 4. It is characterized by graft enlargement, entire
interstitial infiltration by mononuclear inflammatory
cells (particularly in or around glomeruli and the perivas-
cular area), foci of moderate or severe tubulitis, and mild
intimal arteritis (Figs. 6A and B). By POD 5, all five
groups of allografts were in acute rejection Grade III
[31]. In addition to the above morphological changes on
POD 4, all renal allografts at POD 5 were enlarged,
exhibited heavy interstitial infiltration, severe intimal ar-
teritis, and edematous or necrotic tubular cells. ExtensiveFig. 5. Correlation between MRSI reduction and iron staining intensity
in the cortex of renal grafts. The data of MRSI changes and iron staining interstitial hemorrhage was found in the medulla and
intensity are shown as percentage and arbitrary units, respectively. For
diffuse interstitial hemorrhage was seen in the cortexdetailed experimental conditions, see the text and Table 1.
(Figs. 7A and B). In contrast, the morphology of isografts
harvested on POD 4 (Figs. 6C and D) or POD 5 (Figs.
7C and D) is well preserved, with only minor perivascular
iron staining in the cortex and medulla of the isografts and minimal focal interstitial infiltration, and light dilata-
(group VI). However, the intensity is significantly lower tion of renal tubules.
than in the allografts (group IV) 24 hours after an infu-
Immunohistochemistry of the renal graftssion of the same dose (6 mg Fe/kg) of USPIO particles
(Table 2, P 0.0001). Iron staining intensity in the cortex The immunohistochemical results of the renal grafts
of allografts exhibits significant differences among the have revealed that there were no significant variations
five groups (Table 2, P  0.0001), but the iron staining in the numbers of ED1 cells and CD3 cells among
intensity is difficult to detect in the medulla of allografts the five allograft groups, but there was a remarkable
at 24 hours after infusion of different doses of USPIO, difference between isograft and allograft at POD 5 (P
presumably due to a massive hemorrhage (Fig. 3C and 0.0001, Table 3). The distribution of ED1 and CD3
Fig. 7B). Although there is a possible overlap between infiltrates in the renal allografts harvested at POD 5 was
the MRSI reduction caused by the presence of iron and similar among the five groups. A dense infiltration of
by hemorrhage in allografts on POD 5, the iron staining ED1 and CD3 cells was observed in the cortex of all
intensity results from the cortex of allografts match the allografts. They particularly accumulated in or around
MRSI data, confirming that the signal reduction in the glomeruli, vessels, and tubules. However, less staining
MR images is predominantly due to the presence of iron. intensity of ED1 and CD3 cells was observed in the
Figure 5 shows the relation between the intensity of iron necrotic regions of POD 5 allografts, and there was a
decrease in the accumulation of these cells, especiallystaining and the percentage of MRSI reduction due to
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Fig. 6. Hematoxylin and eosin (H&E) stain-
ing shows the pathological changes of POD 4
renal grafts. Representative optical micros-
copy images of H&E staining of grafts from
groups I and VI are shown. The morphological
alteration of the allografts (A for cortex and
B for medulla) appears as acute rejection
grade II [31]. The morphology of the isografts
(C for cortex and D for medulla) was well
preserved. They exhibited only small perivas-
cular and very mild diffusing interstitial infil-
tration, and light dilatation of renal tubules.
Original magnification,100. Detailed exper-
imental conditions are in the text and Table 1.
Fig. 7. H&E staining shows the pathological
changes of POD 5 renal grafts. Representative
images of staining of grafts from groups IV
and VI are shown. Allografts (A for cortex and
B for medulla) were in acute rejection grade
III [31]. In addition to the morphological
changes on POD 4, all renal allografts exhib-
ited heavy interstitial infiltration, severe inti-
mal arteritis, and edematous or necrotic tubu-
lar cells. Extensive interstitial hemorrhage was
found in the medulla, and diffusing interstitial
hemorrhage was seen in the cortex. In con-
trast, the morphology of the isografts (C for
cortex and D for medulla) was well preserved.
Original magnification,100. Detailed exper-
imental conditions are in the text and Table 1.
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Table 3. Histology and immunohistochemistry of kidney grafts at POD 5
Hemorrhagea ED1 Cells (C/FV 400x)b CD3 Cells (C/FV400x)b
Group Cortex Medulla Cortex Medulla Cortex Medulla
I   138.737.98 110.207.20 98.474.93 84.734.13
II   141.2610.63 109.675.85 98.807.07 82.204.84
III   139.727.46 108.675.59 100.225.61 83.784.76
VI   141.485.95 107.816.24 100.295.26 84.144.61
V   142.786.67 108.948.17 99.445.58 84.784.07
VI   16.006.24c 14.803.49c 9.201.92c 7.601.52c
a, , and , none, diffusing or extensive interstitial hemorrhage seen in the grafts, respectively
b The number of cells is presented as mean  SD
c P  0.0001 vs. groups I, II, III, IV, and V
CD3 cells, in the medulla. In contrast to allografts, acute renal allograft rejection [17–22]. Although T-cell–
rich interstitial nephritis is a hallmark of acute allograftthere was only very minor diffuse ED1 and CD3 cell
rejection, macrophages and their associated products mayinfiltration and no obvious difference in distribution of
influence initial and late changes, and may be more im-ED1 and CD3 cells in isografts at POD 5 (results not
portant to the process than previously believed [19–22].shown). Figure 8 indicates that the distribution of USPIO
Hence, our current method, which can provide sequen-particles (Fig. 8A, iron staining) is well correlated with
tial monitoring of the distribution and intensity of infil-the macrophage infiltration in the cortex of the rejecting
trates in the allograft may be more specific and sensitiveallografts (Fig. 8B, ED1 staining). Some discrepancies
than other methods used to detect graft rejection.between these two types of staining are observed. This
The use of dextran-coated USPIO particles as a tissue-may be due to the fact that they were performed on
specific MRI contrast agent is well established [6–17]. Itseparate histological sections.
also has been shown that intravenously injected USPIO
particles have a great advantage in cell-specific labeling
DISCUSSION for MRI studies. First, the cell labeling procedure is
very simple. Second, labeling through endocytosis and/orSeveral MRI techniques have been applied for the
phagocytosis does not affect the functional properties ofdetermination of renal allograft rejection in experimen-
the cells [7, 11, 24]. Renal acute rejection is pathologicallytal animal models [32–35] as well as in human studies
characterized by mononuclear cell infiltration in the in-[36–42]. Most of these early MRI studies focused on
terstitium, arteritis, and tubulitis [32]. Several studiesfunctional MRI, while some of them evaluated the graft
have reported that the peak of infiltrates in this DA→BNstatus by analyzing the anatomical changes of renal allo-
rat acute renal rejection model is about POD 5, and thesegraft based on the loss of corticomedullary differentia-
infiltrates are mostly macrophages and T-cells [17, 43].tion on T1-weighted images [32, 41]. In many aspects, Our data have confirmed these observations (Table 3).these findings were non-specific, because they could be
Weissleder et al demonstrated that 24 hours after intra-seen in acute tubular necrosis and cyclosporine toxicity
venous injection in rats, all USPIO particles were accu-
[36, 38]. Beckman et al have reported that DA→Lewis
mulated in the macrophages [7]. In their study, lymph
rat kidney allografts could be analyzed by T1- and T2- node relaxation times decreased maximally within 24 to
weighted spin-echo images and bolus-tracking perfusion 48 hours after intravenous administration of USPIO. The
assessment [14]. MRI anatomical scores (range 1 to 6) T2 of normal lymph nodes had significantly decreased
and perfusion rates were compared with graft histology 24 hours after administration. Other groups obtained
(range of rejection score 1 to 6). Both in the acute and similar results [12, 13, 16, 17]. Dousset et al demonstrated
chronic phases, the MRI scores correlated significantly that MR signal intensity did not change within 4 to 6
with the histological scores, and the perfusion rates also hours after intravenous administration of USPIO (AMI-
correlated significantly with the MRI score or the histo- 227) even at high doses (17 mg Fe/kg or 300 mol/kg)
logical score. These MRI scores were derived from mor- [12]. They indicated that the time lapse between intrave-
phological images, which showed transverse sections of nous injection and MRSI change is an important parame-
transplanted kidneys in comparison to the contralateral ter that must be established to exceed the blood phase of
native kidney. the free contrast agent molecules, and to allow sufficient
Cell-specific imaging is an increasingly important field time for the iron particles to accumulate within the mac-
of MR imaging [10–13, 16, 17]. It is well known that both rophage phagolysosomes. Our study also has confirmed
that the USPIO particles are mostly accumulated in mac-T-cells and macrophages are involved in the process of
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rophage phagolysosomes 24 hours after infusing with then these cells are attracted to rejecting grafts. The
particles may be directly delivered to the interstitiumUSPIO. We compared the MRSI reduction between pre-
by transcytosis through high endothelial venules in theinfusion at POD 4 and 24 hours after infusion at POD 5.
kidney [7]. They may also move across the rupturedOrgan biodistributions of USPIO particles are widely
vessels that may be caused by a rejection reaction anddifferent. Twenty-four hours after intravenous adminis-
diffuse into the interstitium. Those free particles accumu-tration of USPIO particles, 2.9%, 3.6%, 6.3%, and 7.1%
lated in the interstitium may then be taken up by infil-of the injected dose per gram of tissue was found in bone
trates in the rejecting site and/or are gradually clearedmarrow, lymph nodes, liver, and spleen of normal rats,
through afferent lymphatic vessels. On POD 5, allograftsrespectively [7, 23]. Doussel et al reported that the half
show Grade III acute rejection, arteritis becomes morelife of the USPIO particle (AMI-227) with a dose of
severe, artery lumina are narrowed and/or are obstruc-16.8 mg Fe/kg was about 5 to 6 hours in rat blood [12].
ted, and vessels are ruptured. Therefore, diffuse hemor-Their results indicated that with a high dose (16.8 mg
rhage in the cortex and extensive hemorrhage in theFe/kg) of AMI-227, EAE rats showed signal intensity
medulla are shown in allografts on POD 5 (Fig. 7 A, B).decrease related to iron-coated macrophages in the cen-
Because of low or no blood flow in severely rejectingtral nervous system, but no signal changes were found
grafts [35], the particles distributed to the medulla are
after a low dose (2.5 mg Fe/kg) was given. In our results,
much less than those to the cortex. Severe hemorrhage
significant MRSI reduction in the allografts at POD 5 in the medulla causing the MRSI reduction is not signifi-
was observed 24 hours after an infusion of 6 or 12 mg cantly different among five allograft groups under differ-
Fe/kg of USPIO particles, but no statistically significant ent doses or without USPIO administration (Table 2).
change was obtained when less than 3 mg Fe/kg was given. The effects of hemorrhage on the MRSI reduction may
In another study, we used different dosages of USPIO be distinguished by using group I (only PBS infused) as
to test USPIO-enhanced dynamic MRI in normal rat background reference (Fig. 3C).
[30]. We observed that well-shaped first-pass dynamic Magnetic resonance imaging has the capability of de-
curves are observed only for the doses of 3 and 6 mg tecting both tissue anatomic features and functional sta-
Fe/kg in the cortex and the latter dosage gave a smaller tus of the graft. USPIO particles have a relatively long
deviation and a clearer signal intensity reduction. The half-life in blood (about 2 hours in rats), an intravascular
dynamic curves appeared more rounded and recovery distribution, and can be taken up by infiltrates in allo-
was delayed after maximum signal intensity reduction grafts. Our present study has shown that a dose of 6
mg Fe/kg of dextran-coated USPIO particles gives goodat the dosage of 12 mg Fe/kg. These data indicate that
reduction of the MR signal and minimum standard devia-USPIO particles are cleared from kidney vessels in a time-
tion. By using a dose of 6 mg Fe/kg of USPIO particles,dependent and dose-dependent fashion. Our immuno-
perfusion characteristics of the renal graft can also behistochemical data show no significant difference in num-
shown by dynamic MRI [30]. Hence, measurements ofber of ED1 and CD3 cells among the five renal allograft
renal perfusion followed by detection of macrophagegroups (Table 3). However, there are remarkable differ-
infiltration by MRI after a single administration of dex-ences in the MRSI reduction and iron staining intensity
tran-coated USPIO particles appear to be a useful andbetween high and low doses of USPIO administered.
accurate method to monitor the graft status. This ap-Thus, it is likely that with a higher dose of USPIO parti-
proach also may differentiate graft rejection from CsAcles, the particles remain in the blood phase longer, and
nephrotoxicity, acute tubulopathy, and kidney infectionthere is sufficient time for them to be taken up by circulat-
when dealing with clinical parameters. We plan to carrying macrophages/monocytes and/or transported slowly
out further studies combining dynamic MRI and in vivo
across the capillary endothelium to the interstitium.
cell-labeling MRI to monitor renal rejection by infusion
The present study shows that MRSI reduction is sig- of dextran-coated USPIO particles.
nificantly different in the cortex at different doses, but In summary, our results indicate that there is a good
no statistical difference was found in the medulla among correlation between MRSI reduction and the distribu-
five allograft groups studied (Table 2). The MRSI change tion of USPIO in the cortex, and that the optimal dose
also is correlated with the iron staining intensity in the of dextran-coated USPIO particles to detect the accumu-
cortex, but not in the medulla (results not shown). These lation of the macrophages at the rejecting kidney is about
differences might be due to the blood supply and to 6 mg Fe/kg body weight in our rat model. Hemorrhage
the fact that macrophage infiltration occurs more in the in renal grafts (such as, in the medulla) influences the
cortex than in the medulla at POD 5. After intravenous MRI signal intensity. In conclusion, our results show that
injection, the USPIO particles are distributed in the kid- detecting rat renal acute rejection with MRI following
neys probably through several pathways. They may be an intravenous administration of dextran-coated USPIO
particles appears to be a valuable and promising tooltaken up by circulating macrophages/monocytes and
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